recombinant vector

re·com·bi·nant vec·tor

a vector into which a foreign DNA has been inserted.
Synonym(s): vector (5)

re·com·bi·nant vec·tor

(rē-kom'bi-nănt vek'tŏr)
A vector into which foreign DNA has been inserted.
Synonym(s): vector (5) .

re·com·bi·nant vec·tor

(rē-kom'bi-nănt vek'tŏr)
A vector into which foreign DNA has been inserted.
Synonym(s): vector (5) .
References in periodicals archive ?
Preventive vaccines have been classified based on its types like Live, Attenuated Vaccines, Inactivated vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugated Vaccines, DNA Vaccines, recombinant vector vaccines etc.
For the SW clone, the 267-bp DNA fragment corresponding to the second rhuIFN[alpha]2 wild-type fragment was cut with BglII and inserted into the pGEX4T1/SynrhuIFN[alpha]2a synthetic full-length recombinant vector (P2 vector) cut with the same restriction enzyme.
28 difference ([DELTA][DELTA]CP) (a) Clones containing recombinant vector ([H.
Wyeth Holdings Corporation (Madison, NJ) has patented a process for extracting gram-negative integral membrane proteins from bacteria or bacterial host cells containing a recombinant vector by differential detergent tangential flow diafiltration.
To eradicate AI, the vaccination system must allow the detection of field exposure in a vaccinated flock, which can be achieved by using conventional inactivated vaccines and recombinant vector vaccines.
This has resulted in the introduction of new technologies such as DNA vaccine preparation, T-cell receptor peptide vaccine preparation, recombinant vector vaccine preparation, and immunogenic inactivated cell culture vaccine preparation.
This has resulted in the introduction of new technologies such as dendritic cell vaccine preparation, DNA vaccine preparation, T-cell receptor peptide vaccine preparation, and recombinant vector vaccine preparation.
The vaccine market is divided by technology class (Live/Attenuated, Toxoid, Conjugate, Sub-Unit, Recombinant Vector, DNA, Synthetic, and Dentritic Vaccines), types (Preventive and Therapeutic), end users (Pediatric and Adult), disease indication (Infectious Diseases, Cancer, Allergies, and Others - Diabetes, Cardiovascular Diseases), and geography (North America, Europe, Asia, and Rest of the World).
MitoSciences today announces an agreement with the Hospital for Sick Children (SickKids) in Toronto, Canada, whereby SickKids will provide MitoSciences with recombinant vector systems for producing the four kinases and two phosphatases that activate and deactivate the enzyme PDH (pyruvate dehydrogenase).
When the recombinant vector is administered to mammalian cell culture or using a cell-free transcription/translation system, in vitro, authentic structural proteins of western equine encephalitis virus are produced as verified by reactivity with monoclonal antibodies developed to western equine encephalitis virus.
Technology Class - Live - Toxoid - Conjugate - Sub-Unit - Recombinant Vector Vaccines - DNA Vaccines - Synthetic Vaccines - Dentritic Vaccines

Full browser ?